The Building Owners and Managers Association of Westchester (BOMA) will honor NewYork-Presbyterian and Regeneron Pharmaceuticals at its 34th Annual Hall of Honor Awards Dinner to be held in May. BOMA will also present the President’s Award to Ronald McDonald House Westchester.
The honorees will be recognized for their many contributions to Westchester’s economy. Thursday, May 7 at Abigail Kirsch at Tappan Hill in Tarrytown. For information about tickets and sponsorship opportunities, contact Marianne Carney at (800) 726-6224.
NewYork-Presbyterian
NewYork-Presbyterian is one of the nation’s most comprehensive, integrated academic healthcare systems, encompassing 10 hospitals across the Greater New York area, nearly 200 primary and specialty care clinics and medical groups, and an array of telemedicine services.
In Westchester, the hospital system is anchored by two acute care hospitals: NewYork-Presbyterian Westchester in Bronxville and NewYork-Presbyterian Hudson Valley Hospital in Cortlandt Manor, which offer a full range of inpatient and outpatient services, including cancer care, cardiology, maternal and pediatric care, orthopedics, digestive health, and advanced surgical specialties. Physicians affiliated with Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine provide care across more than 60 specialties throughout Westchester, Rockland, and Putnam counties.
NewYork-Presbyterian recently expanded access to advanced specialty care with the opening of NewYork-Presbyterian The One at 1111 Westchester Ave. in White Plains. The 225,000-square-foot outpatient facility brings together more than 90 adult and pediatric specialties under one roof. With 156 exam rooms, 35 procedure and treatment rooms, and 10 operating rooms, NewYork-Presbyterian The One enhances coordinated, high-acuity outpatient care while strengthening the Westchester Avenue corridor as a premier healthcare destination.
Regeneron
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for serious diseases. Founded and led by physician-scientists, Regeneron has repeatedly translated science into medicine, resulting in 14 Regeneron-invented treatments and about 45 product candidates in development, most of which were discovered in its Tarrytown laboratories. Its medicines and pipeline address eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
The company’s portfolio of medicines includes four marketed “blockbusters” that help millions of patients and generate resources to invest in future innovation. In 2025, total revenues grew to $14.3 billion, and the company employed more than 15,000 people across three continents.
Regeneron also reported clinical data with near-term potential impact in melanoma, multiple myeloma, obesity, and rare diseases; launched two new blood cancer treatments; and secured approvals for multiple new indications and populations. Looking ahead, Regeneron plans to invest about $6 billion in R&D in 2026 and $9 billion in U.S. manufacturing and infrastructure in coming years.
The dinner will also feature the winners of the Best of BOMA Westchester County Signature Awards, which include Tenant Fit Out, Best Amenities, Curb Appeal/Common Area, Retail Addition to the Market and Unsung Hero.
